Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Chubb
Cerilliant
Federal Trade Commission
Medtronic
Citi
US Army
Baxter
Accenture

Generated: May 23, 2018

DrugPatentWatch Database Preview

PSORCON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Summary for PSORCON
US Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: 34
Patent Applications: 3,932
DailyMed Link:PSORCON at DailyMed
Drug patent expirations by year for PSORCON
Synonyms for PSORCON
(6alpha,11beta,16beta)-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-bis(fluoranyl)-10,13,16-trimethyl-11-oxidanyl-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate
[2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
2-[(1R,2S,8S,10S,11S,13S,14R,15S,17S)-14-(ACETYLOXY)-1,8-DIFLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
33564-31-7
564D317
6alpha-Fluorobetamethasone-17,21 diacetate
6alpha,9-difluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16 beta-methyl-pregna-1,4-diene-3,20-dione 17,21-diacetate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-diacetate
7W2J09SCWX
A821840
AB00489907
AB2000740
AC-3515
AC1L2G4E
AC1Q62MX
acetic acid [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester
Acetic acid diflorasone
AKOS025402039
AN-6747
Apexicon e
BC226395
BCP9000608
BOBLHFUVNSFZPJ-JOYXJVLSSA-N
BPBio1_000614
BRD-K17674993-001-03-1
BRN 2318163
BSPBio_000558
CAS-33564-31-7
CCG-220619
CHEBI:31483
CHEMBL1200545
CTK8F9190
D01327
D0G7KJ
Dermaflor
Diacort
diflorasone 17,21-diacetate
Diflorasone di(acetate)
Diflorasone diacetate
Diflorasone diacetate (JP17/USP)
Diflorasone diacetate [USAN:JAN]
Diflorasone diacetate [USAN:USP:JAN]
Diflorasone diacetate, United States Pharmacopeia (USP) Reference Standard
DSSTox_CID_25646
DSSTox_GSID_45646
DSSTox_RID_81024
DTXSID8045646
EINECS 251-575-1
Florone (TN)
Florone E
FT-0639113
GTPL7068
HMS1569L20
HMS2096L20
HMS2231D10
LS-118428
Maxiflor
MLS000069559
MLS001076548
Murode
NCGC00022003-03
NCGC00022003-04
NCGC00022003-06
Opera_ID_1660
PL000439
Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-, (6alpha,11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-,(6-alpha,11-beta,16-beta)-
Prestwick0_000619
Prestwick1_000619
Prestwick2_000619
Prestwick3_000619
Psorcon (TN)
Psorcon E
Q-101374
Q944
REGID_for_CID_71414
SC-80650
SCHEMBL4556
SMR000058814
SPBio_002777
SR-01000000122
SR-01000000122-3
Tox21_110875
Tox21_110875_1
U 34865
U-34,865
U-34865
UNII-7W2J09SCWX
ZINC4212938

US Patents and Regulatory Information for PSORCON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms North PSORCON diflorasone diacetate CREAM;TOPICAL 020205-001 Nov 20, 1992 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PSORCON diflorasone diacetate OINTMENT;TOPICAL 019260-001 Aug 28, 1985 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PSORCON E diflorasone diacetate OINTMENT;TOPICAL 017994-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Johnson and Johnson
Mallinckrodt
Cipla
Express Scripts
Argus Health
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.